STAT+: Vera kidney drug Trutakna shows strong final results in Phase 3 trial
Vera Therapeutics said Tuesday that its recently approved drug Trutakna stabilized kidney function and reduced the risk of kidney-related death and other complications in patients with a chronic autoimmune kidney disease, according to final…
ImpactNotable 49/100
Why it mattersRule-based estimate: event keywords (+20); trust 8/10.
RegionsGlobal
Published4 d ago (Tue, 15 Sep 2026 10:30:00 GMT)
RetrievedWed, 16 Sep 2026 00:01:10 GMT via rss
ClassifiedWed, 16 Sep 2026 00:01:24 GMT by heuristic
AuthorAdam Feuerstein